Governor Kristi Noem (R) signed a measure requiring South Dakota’s registered medical cannabis patients to acknowledge in writing that they are aware of being barred from owning a firearm in keeping with federal law.
House Bill 1024, introduced by state Rep. Kevin Jensen (R), cleared the state legislature recently. Initially, the bill sought to have patients sign their names on the medical marijuana application form acknowledging the federal gun rule, but the state Senate Health and Human Services Committee amended it before green-lighting it.
Meanwhile, the state Senators killed a separate bill that House members advanced in mid-January that would have compelled cannabis shops to warn customers of the federal firearms ban.
In addition to Rep. Jensen's bill, Gov. Noem approved four other measures aimed at promoting public health.
"These bills will keep South Dakotans safe and healthy," Noem said in a press release. "When xylazine, otherwise known as the ‘zombie' drug, is mixed with fentanyl, it makes an already deadly drug even deadlier, and it brings with it a whole host of negative health consequences. I am proud to sign legislation that keeps our healthcare professions fair and protects people from deadly drugs."
Jensen said earlier the bills do not infringe on a South Dakotan's ability to get a medical marijuana card, reported Dakota News Now, but rather provide necessary information for making informed decisions.
"All this bill (HB1024) would require on the application for a medical marijuana card is the same language used on the federal form (to purchase a firearm)," he said. "It is simply to inform the public that this is federal law."
Benzinga Cannabis Conferences are coming to Los Angeles. Join the Benzinga Cannabis Market Spotlight: California, and unlock the future of cannabis at the premier networking event in Culver City on February 22. Connect with top industry leaders, gain insider insights into the investment landscape and shape the evolving markets in California and beyond. Don't miss this chance to be at the forefront of the cannabis industry's growth and innovation! Join now.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.